Cargando…

S92. REASONS TO START SMOKING CANNABIS: A CASE CONTROL-ANALYSIS FROM THE EUGEI STUDY

BACKGROUND: Studies have shown that cannabis can increase the risk of psychosis from 1.7 to 3.9 times. Both frequency and potency seem to contribute to differences in the incidence of psychosis across Europe. Despite this evidence, sceptics argue that that the association between cannabis use and ps...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spinazzola, Edoardo, Rodriguez, Victoria, Quattrone, Diego, Trotta, Giulia, Di Forti, Marta, Murray, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session I
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234283/ http://dx.doi.org/10.1093/schbul/sbaa031.158

Ejemplares similares

T170. GENE AND ENVIRONMENT INTERPLAY AMONG DIAGNOSTIC CATEGORIES IN THE EUGEI STUDY
por: Rodriguez, Victoria, et al.
Publicado: (2020)

S126. THE RELATION OF THE PSYCHOSIS CONTINUUM WITH SCHIZOPHRENIA POLYGENIC RISK SCORE AND CANNABIS USE
por: Quattrone, Diego, et al.
Publicado: (2020)

S115. EVALUATION OF THE CLINICAL UTILITY OF SYMPTOM DIMENSIONS ON LONG-TERM CLINICAL AND FUNCTIONAL OUTCOMES IN FIRST EPISODE PSYCHOSIS
por: Bor, Ege, et al.
Publicado: (2020)

5.4 BIOLOGICAL AND EPIDEMIOLOGICAL EXAMINATION OF TRANSDIAGNOSTIC AND SPECIFIC SYMPTOM DIMENSIONS AT PSYCHOSIS ONSET: FINDINGS FROM THE EUGEI STUDY
por: Quattrone, Diego, et al.
Publicado: (2018)

Adverse effects of heavy cannabis use: even plants can harm the brain
por: Sideli, Lucia, et al.
Publicado: (2021)

S118. TRANSDIAGNOSTIC SYMPTOM DIMENSIONS OF PSYCHOSIS AND THE PREDICTIVE ROLE OF PREMORBID ADJUSTMENT AND COGNITIVE CHARACTERISTICS IN THE MULTINATIONAL EU-GEI STUDY
por: Ferraro, Laura, et al.
Publicado: (2020)

S98. THE RELATIONSHIPS AMONG CANNABIS USE, ABERRANT SALIENCE, AND SCHIZOTYPY
Publicado: (2020)

O8.4. ENVIRONMENTAL RISK FACTORS IN BIPOLAR DISORDER AND PSYCHOTIC DEPRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PROSPECTIVE STUDIES
por: Rodriguez, Victoria, et al.
Publicado: (2020)

S186. THE EFFECTS OF CHILDHOOD TRAUMA ON HIPPOCAMPAL VOLUME IN FIRST EPISODE PSYCHOSIS: DOES CORTISOL PLAY A ROLE?
por: Ciufolini, Simone, et al.
Publicado: (2020)

S192. EFFECTS OF NICOTINE INTAKE ON NEUROPLASTICITY IN SMOKING AND NON-SMOKING PATIENTS WITH SCHIZOPHRENIA
por: Pross, Benjamin, et al.
Publicado: (2020)

S96. EXAMINING DIFFERENCES BETWEEN CURRENT CANNABIS CONSUMPTION AND COGNITIVE FUNCTIONING OF FIRST-EPISODE PSYCHOSIS PATIENTS: A RETROSPECTIVE STUDY
por: Pochiet, Gabrielle, et al.
Publicado: (2020)

S94. PREDICTION OF CANNABIS RELAPSE IN CLINICAL HIGH-RISK INDIVIDUALS AND RECENT ONSET PSYCHOSIS - PRELIMINARY RESULTS FROM THE PRONIA STUDY
por: Penzel, Nora, et al.
Publicado: (2020)

The Impact of the COVID-19 Pandemic on the Incidence of First Episode Psychosis in South London
por: Meyer, Zeryab, et al.
Publicado: (2022)

S154. TOBACCO SMOKING AND CLINICAL HIGH RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EVIDENCE
por: De Micheli, Andrea, et al.
Publicado: (2020)

M116. A SYSTEMATIC REVIEW OF THE PSYCHOLOGICAL AND BIOLOGICAL MEDIATORS BETWEEN ADVERSITY AND PSYCHOSIS: POTENTIAL TARGETS FOR TREATMENT
por: Alameda, Luis, et al.
Publicado: (2020)

S93. ADHD SYMPTOMS AND DAILY SMOKING AT AGE 15–16 YEARS AND PSYCHOTIC DISORDER IN EARLY ADULTHOOD. FINDINGS FROM THE NORTHERN FINLAND BIRTH COHORT 1986 STUDY
por: Niemelä, Solja, et al.
Publicado: (2020)

The effect of the COVID-19 pandemic on the treated incidence of psychotic disorders in South London
por: Quattrone, D., et al.
Publicado: (2023)

T52. COGNITION, METACOGNITION AND SOCIAL COGNITION AFTER A FIRST EPISODE PSYCHOSIS. PRELIMINARY RESULTS FROM A 5-YEAR-FOLLOW-UP STUDY
por: Tripoli, Giada, et al.
Publicado: (2020)

S170. PROGRESSIVE SUBCORTICAL VOLUME LOSS IN TREATMENT-RESISTANT SCHIZOPHRENIA PATIENTS AFTER COMMENCING CLOZAPINE TREATMENT
por: Tronchin, Giulia, et al.
Publicado: (2020)

S201. HIPPOCAMPAL SUBFIELD VOLUMES AND CHANGE IN BODY MASS OVER 12 MONTHS OF TREATMENT IN FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDERS
por: Du Plessis, Stéfan, et al.
Publicado: (2020)

S21. CORRELATES AND TRANSITION RATE OF CHILDREN AND ADOLESCENTS WITH ATTENUATED PSYCHOTIC SYMPTOMS: FINDINGS FROM A LONGITUDINAL STUDY
por: Molteni, Silvia, et al.
Publicado: (2020)

S80. CHILDHOOD TRAUMA AND SOCIAL COGNITION IN DELUSIONAL PSYCHOSES
por: Díaz-Caneja, Covadonga, et al.
Publicado: (2020)

Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?
por: Hindocha, Chandni, et al.
Publicado: (2020)

S67. TREATMENT-RESISTANCE AFFECTS LONG-TERM COGNITIVE TRAJECTORIES IN SCHIZOPHRENIA: A LONGITUDINAL STUDY
por: Spangaro, Marco, et al.
Publicado: (2020)

S127. MORTALITY IN PSYCHIATRIC PATIENTS WITH AT LEAST NINE-YEAR FOLLOW-UP PERIOD AFTER THEIR FIRST HOSPITAL ADMISSION: A BRAZILIAN COHORT STUDY
por: Leite da Roza, Daiane, et al.
Publicado: (2020)

S180. THE SELECTIVE GPR139 AGONIST TAK-041 REVERSES ANHEDONIA AND SOCIAL INTERACTION DEFICITS IN RODENT MODELS RELATED TO NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
por: Schiffer, Hans, et al.
Publicado: (2020)

S56. SWITCHING FROM RISPERIDONE TO PALIPERIDONE PALMITATE IN SCHIZOPHRENIA: CHANGES IN COGNITIVE FUNCTION
por: Tost Bonet, Meritxell, et al.
Publicado: (2020)

S128. IMPACT OF COMORBIDITIES ON SURVIVAL ESTIMATE FOR PATIENTS WITH MENTAL DISORDERS
por: Gonçalves de Rezende, Marcos, et al.
Publicado: (2020)

O12.4. SOME OF THE INDIVIDUAL DIFFERENCES IN RISK TO DEVELOP PSYCHOSIS AMONG CANNABIS USERS CAN BE EXPLAINED BY WHERE THEY LIVE AND BY THEIR AGE AT FIRST USE
por: Di Forti, Marta, et al.
Publicado: (2018)

S29. ONE-CARBON METABOLISM AND STRESS IN CHILDREN AND ADOLESCENTS WITH PSYCHOSIS RISK SYNDROME: PRELIMINARY DATA
por: Baeza, Inmaculada, et al.
Publicado: (2020)

S95. DIFFERENCES IN LIFETIME PATTERNS OF PSYCHOSTIMULANTS AND THEIR IMPACT ON THE PROPORTION OF PATIENTS WITH FIRST-EPISODE PSYCHOSIS ATTRIBUTABLE TO PSYCHOSTIMULANTS USE ACROSS EUROPE
por: Duran-Cutilla, Manuel, et al.
Publicado: (2020)

S8. GRIN1 PROMOTER METHYLATION CHANGES IN BLOOD OF EARLY-ONSET PSYCHOTIC PATIENTS AND UNAFFECTED SIBLINGS WITH CHILDHOOD TRAUMA
por: Loureiro, Camila, et al.
Publicado: (2020)

T110. FIRST EPISODE PSYCHOTIC PATIENTS WITH A HISTORY OF FREQUENT CANNABIS USE EXPRESS MORE POSITIVE SYMPTOMS AT ILLNESS ONSET THAN THOSE WHO NEVER USED CANNABIS
por: Quattrone, Diego, et al.
Publicado: (2018)

S202. PROXIMAL AND DISTAL FACTORS ASSOCIATED WITH CLOZAPINE EXPOSURE IN A SAMPLE OF TREATMENT RESISTANT AND TREATMENT RESPONSIVE SCHIZOPHRENIA PATIENTS
por: Barone, Annarita, et al.
Publicado: (2020)

S70. PROFILES OF SOCIAL COGNITION AND METACOGNITION IN FIRST-EPISODE PSYCHOSIS: A LATENT PROFILE ANALYSIS
por: Ferrer-Quintero, Marta, et al.
Publicado: (2020)

35.4 A PUBLIC HEALTH APPROACH TO THE PREVENTION OF PSYCHOSIS
por: Murray, Robin, et al.
Publicado: (2018)

Racial Disparities and Risk for COVID-19 Among Pregnant Patients: Results from the Michigan Statewide Collaborative
por: Ismailova, Inara, et al.
Publicado: (2022)

Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
por: Erzin, Gamze, et al.
Publicado: (2021)

The association between exposome score for schizophrenia and metabolic parameters in individuals with schizophrenia and healthy controls: Findings from the EUGEI study
por: Erzin, G., et al.
Publicado: (2023)

Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Findings from the EUGEI study
por: Fusar-Poli, L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qblradosjm90m2k60cn9qbm52b